Italy's Silicon Biosystems Opens US Office to Sell DEPArray Cell-Analysis Platform

The Italian biochip firm has established an office in San Diego from which it aims to target the US market and eventually steer its DEPArray cell analysis platform into the clinic.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.